PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer

Docetaxel (Dtxl) is currently the most common therapeutic option for prostate cancer (PC). However, adverse side effects and problems associated with chemo-resistance limit its therapeutic outcome in clinical settings. A targeted nanoparticle system to improve its delivery to and activity at the tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Colloids Surf B Biointerfaces
Main Authors: Nagesh, Prashanth K.B., Johnson, Nia R., Boya, Vijaya K.N., Chowdhury, Pallabita, Othman, Shadi F., Khalilzad-Sharghi, Vahid, Hafeez, Bilal B., Ganju, Aditya, Khan, Sheema, Behrman, Stephen W., Zafar, Nadeem, Chauhan, Subhash C., Jaggi, Meena, Yallapu, Murali M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5100699/
https://ncbi.nlm.nih.gov/pubmed/27058278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.colsurfb.2016.03.071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados